FKRP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.266200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.957800E-01
Normal-vs-Stage2
1.309380E-01
Normal-vs-Stage3
4.745500E-02
Normal-vs-Stage4
8.741800E-01
Stage1-vs-Stage2
3.366200E-01
Stage1-vs-Stage3
2.196400E-01
Stage1-vs-Stage4
9.070800E-01
Stage2-vs-Stage3
2.710600E-01
Stage2-vs-Stage4
1.430770E-01
Stage3-vs-Stage4
1.257200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.769400E-01
Normal-vs-AfricanAmerican
8.633800E-02
Normal-vs-Asian
8.807600E-02
Caucasian-vs-AfricanAmerican
7.600800E-01
Caucasian-vs-Asian
2.077600E-01
AfricanAmerican-vs-Asian
4.655800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.903600E-01
Normal-vs-Female
3.875800E-01
Male-vs-Female
6.197000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.221600E-01
Normal-vs-Age(41-60Yrs)
4.858000E-01
Normal-vs-Age(61-80Yrs)
2.672200E-01
Normal-vs-Age(81-100Yrs)
1.803950E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.807600E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.118000E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.456000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.161380E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.581900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.240980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.937600E-02
Normal-vs-Daily Drinker
3.274200E-01
Normal-vs-Weekly Drinker
2.258400E-01
Normal-vs-Occasional Drinker
9.371400E-01
Normal-vs-Social Drinker
2.015400E-01
Non Drinker-vs-Daily Drinker
1.365010E-01
Non Drinker-vs-Weekly Drinker
1.704200E-01
Non Drinker-vs-Occasional Drinker
3.618100E-02
Non Drinker-vs-Social Drinker
9.993800E-02
Daily Drinker-vs-Weekly Drinker
9.356200E-01
Daily Drinker-vs-Occasional Drinker
2.121200E-01
Daily Drinker-vs-Social Drinker
9.565200E-01
Weekly Drinker-vs-Occasional Drinker
2.149400E-01
Weekly Drinker-vs-Social Drinker
8.817600E-01
Occasional Drinker-vs-Social Drinker
2.358800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.521200E-01
Normal-vs-Grade 2
7.581800E-01
Normal-vs-Grade 3
2.815200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.908000E-02
Grade 1-vs-Grade 3
3.009600E-01
Grade 1-vs-Grade 4
3.521200E-01
Grade 2-vs-Grade 3
8.447900E-02
Grade 2-vs-Grade 4
7.581800E-01
Grade 3-vs-Grade 4
2.815200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.752570E-01
Normal-vs-NonDiabetic
4.448200E-01
Diabetic-vs-NonDiabetic
2.202800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.885190E-01
Normal-vs-NoPancreatitis
3.786400E-01
Pancreatitis-vs-NoPancreatitis
5.909600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.960600E-01
Normal-vs-N1
1.712840E-01
N0-vs-N1
2.510800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.143750E-01
Normal-vs-TP53-NonMutant
3.827800E-01
TP53-Mutant-vs-TP53-NonMutant
2.795000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
